Phentermine–topiramate extended-release reduces progression to T2DM

被引：0

|

作者：

机构：

来源：

Nature Reviews Endocrinology | 2014年 / 10卷 / 1期

关键词：

D O I：

10.1038/nrendo.2013.217

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：4 / 4

相关论文

共 50 条

[31] The efficacy and tolerability of topiramate controlled-release in the treatment of obese type 2 diabetes (T2DM) managed with diet or metformin
Rosenstock, J
Hollander, P
Gadde, KM
Leung, AT
Sun, X
Strauss, R
DIABETES, 2005, 54 : A12 - A12
[32] Development and Optimization of Once-Daily Extended-Release Formulations of Topiramate
Lambrecht, Lawrence J.
Todd, Wesley M.
Halvorsen, Mark B.
NEUROLOGY, 2011, 76 (09) : A50 - A50
[33] Pragmatic Assessment of Trokendi XR® (extended-release Topiramate) in Migraine Prevention
O'Neal, W.
Hur, E.
Liranso, T.
Barr, P.
HEADACHE, 2017, 57 : 180 - 180
[34] Extended-Release Topiramate Exhibits Linear and Dose-Proportional Pharmacokinetics
Braun, Tricia L.
Lambrecht, Lawrence J.
Todd, Wesley M.
Halvorsen, Mark B.
Braun, T. L.
ANNALS OF NEUROLOGY, 2012, 72 : S54 - S54
[35] Safety assessment of combination therapies in the treatment of obesity: focus on naltrexone/bupropion extended release and phentermine-topiramate extended release
Halpern, Bruno
Mancini, Marcio C.
EXPERT OPINION ON DRUG SAFETY, 2017, 16 (01) : 27 - 39
[36] Adiponectin in onset and progression of T2DM with cardiac dysfunction in rats
Gupta, C.
Bubber, P.
Fahim, M.
Saidullah, B.
Omanwar, S.
HUMAN & EXPERIMENTAL TOXICOLOGY, 2020, 39 (11) : 1463 - 1474
[37] Decreased progression to diabetes in subjects with prediabetes after 2 years of treatment with controlled-release phentermine/topiramate
Garvey, W. T.
Troupin, B.
Day, W. W.
DIABETOLOGIA, 2011, 54 : S371 - S371
[38] Changes in Glycemic Parameters and Antidiabetic Medication Use by Degree of Weight Loss (WL) With Lifestyle Modification and Phentermine/Topiramate Extended-Release (PHEN/TPM ER)
Kushner, Robert
Troupin, Barbara
DIABETES, 2013, 62 : A544 - A545
[39] Phentermine/Topiramate Extended Release for the Treatment of Adolescent Obesity: A Randomized, Placebo-Controlled Trial
Kelly, Aaron
Bensignor, Megan
Hsia, Daniel
Shoemaker, Ashley
Shih, Winnie
Peterson, Craig
Varghese, Santosh
HORMONE RESEARCH IN PAEDIATRICS, 2022, 95 (SUPPL 1): : 177 - 178
[40] CARDIOVASCULAR EFFECTS BASED ON MAGNITUDE OF WEIGHT LOSS (WL) IN OBESE/OVERWEIGHT SUBJECTS WITH HYPERTENSION RECEIVING PHENTERMINE AND TOPIRAMATE EXTENDED-RELEASE (PHEN/TPM ER)
Bakris, George
Davidson, Michael H.
Gupta, Alok K.
JOURNAL OF CLINICAL HYPERTENSION, 2013, 15 (07): : 517 - 517

← 1 2 3 4 5 →